Medicare Drug Price Negotiation
Medicare negotiated drug prices
The first 10 negotiated prices took effect on January 1, 2026. Fifteen more start January 1, 2027, and another 15 - including the first Part B drugs - in 2028. Here is every drug, its list price and its negotiated "maximum fair price", and what it means for what you pay.
2026: 10 drugs (in effect)
| Drug | List price | Negotiated | Cut |
|---|---|---|---|
| Januvia sitagliptin | $527.00 | $113.00 | -79% |
| NovoLog / Fiasp insulin aspart | $495.00 | $119.00 | -76% |
| Farxiga dapagliflozin | $556.00 | $178.50 | -68% |
| Enbrel etanercept | $7,106.00 | $2,355.00 | -67% |
| Jardiance empagliflozin | $573.00 | $197.00 | -66% |
| Stelara ustekinumab | $13,836.00 | $4,695.00 | -66% |
| Xarelto rivaroxaban | $517.00 | $197.00 | -62% |
| Eliquis apixaban | $521.00 | $231.00 | -56% |
| Entresto sacubitril / valsartan | $628.00 | $295.00 | -53% |
| Imbruvica ibrutinib | $14,934.00 | $9,319.00 | -38% |
Prices for a 30-day supply. List prices are from 2023.
2027: 15 drugs (from January 1, 2027)
| Drug | List price | Negotiated | Cut |
|---|---|---|---|
| Janumet / Janumet XR sitagliptin / metformin | $526.00 | $80.00 | -85% |
| Tradjenta linagliptin | $488.00 | $78.00 | -84% |
| Breo Ellipta fluticasone furoate / vilanterol | $397.00 | $67.00 | -83% |
| Linzess linaclotide | $539.00 | $136.00 | -75% |
| Trelegy Ellipta fluticasone furoate / umeclidinium / vilanterol | $654.00 | $175.00 | -73% |
| Ozempic / Rybelsus / Wegovy semaglutide | $959.00 | $274.00 | -71% |
| Otezla apremilast | $4,722.00 | $1,650.00 | -65% |
| Xifaxan rifaximin | $2,696.00 | $1,000.00 | -63% |
| Pomalyst pomalidomide | $21,744.00 | $8,650.00 | -60% |
| Ibrance palbociclib | $15,741.00 | $7,871.00 | -50% |
| Ofev nintedanib | $12,622.00 | $6,350.00 | -50% |
| Xtandi enzalutamide | $13,480.00 | $7,004.00 | -48% |
| Vraylar cariprazine | $1,376.00 | $770.00 | -44% |
| Calquence acalabrutinib | $14,228.00 | $8,600.00 | -40% |
| Austedo / Austedo XR deutetrabenazine | $6,623.00 | $4,093.00 | -38% |
Prices for a 30-day supply. List prices are from 2024.
2028: 15 drugs (from January 1, 2028)
| Drug | Price |
|---|---|
| Anoro Ellipta umeclidinium / vilanterol | Published by Nov 30, 2026 |
| Biktarvy bictegravir / emtricitabine / tenofovir alafenamide | Published by Nov 30, 2026 |
| Botox onabotulinumtoxinA · Part B | Published by Nov 30, 2026 |
| Cimzia certolizumab pegol · Part B | Published by Nov 30, 2026 |
| Cosentyx secukinumab | Published by Nov 30, 2026 |
| Entyvio vedolizumab · Part B | Published by Nov 30, 2026 |
| Erleada apalutamide | Published by Nov 30, 2026 |
| Kisqali ribociclib | Published by Nov 30, 2026 |
| Lenvima lenvatinib | Published by Nov 30, 2026 |
| Orencia abatacept · Part B | Published by Nov 30, 2026 |
| Rexulti brexpiprazole | Published by Nov 30, 2026 |
| Trulicity dulaglutide | Published by Nov 30, 2026 |
| Verzenio abemaciclib | Published by Nov 30, 2026 |
| Xeljanz tofacitinib | Published by Nov 30, 2026 |
| Xolair omalizumab · Part B | Published by Nov 30, 2026 |
What it means for what you pay
- The negotiated price is what Medicare drug plans pay. Your cost at the counter depends on your plan's copay or coinsurance, not on the list price alone.
- With coinsurance (a percentage), a lower price lowers your cost directly. With a flat copay, it may not change.
- Part D out-of-pocket costs are capped at $2,100 in 2026, so people who reach the cap already pay nothing more that year.
- The negotiated prices apply to Medicare only - not to private insurance or cash prices.
How the negotiation works
- Medicare picks high-spending drugs with no generic or biosimilar competition, years after approval.
- It negotiates a "maximum fair price" with the maker; the price takes effect about 14 months later.
- Up to 15 drugs are added for 2027 and 2028, and up to 20 a year after that.
- A drug leaves the program once a generic or biosimilar comes to market.
Questions about Medicare's negotiated prices
No comments yet. Questions, tips, what worked for you - start the conversation.
Get drug price alerts
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.